August 02, 2021
Anifrolumab (Saphnelo; AstraZeneca) significantly improves disease activity and reduces corticosteroid use in patients with SLE.
July 16, 2021
Individuals with irritable bowel syndrome with constipation indicated that although their symptoms worsened during the pandemic, they did not seek medical care.
July 05, 2021
Pharmacists must keep up to date with the latest in irritable bowel syndrome management.
June 28, 2021
At the virtual Scientific Sessions for the American Diabetes Association, a study shows that metformin can improve adolescent type 1 diabetes.
June 25, 2021
A study presented during a poster session at the American Diabetes Association Virtual 81st Scientific Sessions evaluated performance, safety, and satisfaction of an extended-wear insulin infusion set in patients with type 1 diabetes.
June 07, 2021
Aducanumab (Aduhelm; Biogen) is the first approved novel treatment for Alzheimer disease since 2003.
Exposure to heat and sun can worsen symptoms for certain conditions.
May 06, 2021
Pharmacists can play an important role as part of an interdisciplinary team in treating patients with rheumatoid arthritis.
April 26, 2021
Tremfya phase 3 data shows skin clearance rates were maintained at 5 years with 55.5% of patients achieving an IGA score of 0% and 53% achieving PASI 100 response in VOYAGE 2 trial.
April 21, 2021
Research presented at Academy of Managed Care Pharmacy’s 2021 virtual conference evaluated tolerance and adherence to oral disease-modifying therapies for relapsing-remitting multiple sclerosis.
